Nu-Doxycycline en es it fr

Nu-Doxycycline Brand names, Nu-Doxycycline Analogs

Nu-Doxycycline Brand Names Mixture

  • No information avaliable

Nu-Doxycycline Chemical_Formula


Nu-Doxycycline RX_link

Nu-Doxycycline fda sheet

Nu-Doxycycline FDA

Nu-Doxycycline msds (material safety sheet)

Nu-Doxycycline MSDS

Nu-Doxycycline Synthesis Reference

C. R. Stephens et al.; J. Am. Chem. Soc. 80; 5324 (1958)

Nu-Doxycycline Molecular Weight

444.435 g/mol

Nu-Doxycycline Melting Point

201 oC

Nu-Doxycycline H2O Solubility

630 mg/L

Nu-Doxycycline State


Nu-Doxycycline LogP


Nu-Doxycycline Dosage Forms

Tablet; Capsule; Gel; Liquid; Powder; Powder for solution

Nu-Doxycycline Indication

For the treatment of the following infections:Rocky mountain spotted fever, typhus fever and the typhus group, Q fever, rickettsialpox, and tick fevers caused by Rickettsiae, Chancroid caused by Haemophilus ducreyi, Uncomplicated gonorrhea caused by Neisseria gonorrhoeae, Respiratory tract infections caused by Mycoplasma pneumoniae or Streptococcus pneumoniae. Lymphogranuloma ve

Nu-Doxycycline Pharmacology

Doxycycline, a long-acting tetracycline derived from oxytetracycline, is used to inhibit bacterial protein synthesis and treat non-gonococcal urethritis and cervicitis, exacerbations of bronchitis in patients with COPD, and adult periodontitis.

Nu-Doxycycline Absorption

completely absorbed after oral administration

Nu-Doxycycline side effects and Toxicity

anorexia, nausea, diarrhoea, glossitis, dysphagia, enterocolitis and inflammatory lesions (with monilial overgrowth) in the anogenital region. skin reactions such as maculopapular and erythematous rashes, exfoliative dermatitis, photosensitivity, hypersensitivity reactions such as urticaria, angioneurotic oedema, anaphylaxis, anaphyl-actoid purpura, pericarditis, and exacerbation of systemic lupus erythematosus, benign intracranial hypertension in adults disappearing on discontinuation of the medicine, haematologic abnormalities such as haemolytic anaemia, thrombocytopenia, neutropenia, and eosinophilia. LD50=262 mg/kg(i.p. in rat)

Nu-Doxycycline Patient Information

Nu-Doxycycline Organisms Affected

Enteric bacteria and other eubacteria